Mysimba vs Ozempic UK | Expert Comparison | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Mysimba vs Ozempic From Cured Pharmacy

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW 10 % off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £135.00 10% discount using discount code WEIGHTLOSSNEW
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen - UK-licensed prescription Treatment
Treatment

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From £145.00

Future orders save 5%
Start Assessment
Wegovy (Semaglutide) Weight Loss Injection - UK-licensed prescription Treatment
Treatment

Wegovy (Semaglutide) Weight Loss Injection

From £89.00

Future orders save 5%
Start Assessment
Saxenda - UK-licensed prescription Treatment
Treatment

Saxenda

From £68.00

Future orders save 5%
Start Assessment
Orlistat - UK-licensed prescription Treatment
Treatment

Orlistat

From £32.00

Future orders save 5%
Start Assessment
Xenical Orlistat 120mg Capsules - UK-licensed prescription Treatment
Treatment

Xenical Orlistat 120mg Capsules

From £49.99

Future orders save 5%
Start Assessment
Alli Weight Loss Capsules 60mg - UK-licensed prescription Treatment
Treatment

Alli Weight Loss Capsules 60mg

From £49.99

Future orders save 5%
Start Assessment

Mysimba vs Ozempic UK Comparison: Which Weight Loss Treatment Is Right for You?

Published on: June 03, 2026

Choosing between treatments requires understanding how each works. This mysimba vs ozempic uk comparison examines two fundamentally different approaches to weight management, helping you make an informed decision with guidance from our UK-registered clinical team. At Cured Pharmacy, we offer transparent pricing and expert consultations to determine which option suits your individual circumstances.

How Mysimba and Ozempic Work: Different Mechanisms Explained

Mysimba is an oral tablet combining naltrexone 8mg and bupropion 90mg, working centrally on the brain's reward and appetite pathways [1]. It modulates neurotransmitter activity in the hypothalamus and mesolimbic reward system, reducing food cravings and helping patients feel satisfied with smaller portions. Unlike injectable treatments, Mysimba requires daily oral administration with gradual dose escalation over four weeks.

Ozempic contains semaglutide, a GLP-1 receptor agonist administered via weekly subcutaneous injection. It mimics the natural hormone GLP-1, slowing gastric emptying, enhancing insulin secretion, and reducing appetite through both peripheral and central mechanisms [2]. While Ozempic is primarily licensed for type 2 diabetes management in the UK, its sister product Wegovy contains the same active ingredient and is specifically licensed for weight management.

The fundamental difference lies in their approach: Mysimba targets neurological appetite regulation through oral medication, whilst semaglutide-based treatments work through hormonal pathways via injection. This distinction affects everything from administration convenience to side effect profiles and clinical outcomes.

Clinical Efficacy: Mysimba vs Ozempic Weight Loss Results

In the COR-I trial, patients taking Mysimba achieved an average weight loss of 5-6% of their initial body weight over 56 weeks when combined with lifestyle modifications [1]. Approximately 50% of participants achieved at least 5% weight reduction, whilst 25% reached the 10% threshold. These results demonstrate consistent but moderate efficacy for oral neurological appetite modulation.

Semaglutide demonstrates significantly greater weight reduction in clinical trials. The STEP 1 trial showed participants on semaglutide 2.4mg achieved an average 14.9% body weight reduction over 68 weeks, with 86.4% of patients losing at least 5% and 69.1% achieving 10% or greater reduction [2]. These outcomes represent substantially higher efficacy compared to oral appetite modulators, though individual responses vary considerably.

It's essential to understand that clinical trial results represent averages under controlled conditions with intensive lifestyle support. Your individual response depends on multiple factors including baseline weight, adherence to dietary modifications, physical activity levels, and metabolic characteristics. Both treatments require clinical assessment and ongoing monitoring by UK prescribers.

Realistic Expectations for Weight Loss Outcomes

Neither medication guarantees specific weight loss amounts, and both work most effectively when combined with reduced-calorie nutrition and increased physical activity. Our clinical team at Cured Pharmacy emphasises that sustainable weight management requires comprehensive lifestyle changes alongside pharmacological support. Subject to prescriber approval, treatment selection considers your medical history, previous weight loss attempts, and personal preferences regarding administration method.

Side Effects and Tolerability: What UK Patients Experience

Mysimba's most common side effects relate to its neurological mechanism, including nausea (affecting approximately 30% of users initially), headache, constipation, dizziness, and insomnia [1]. These effects typically diminish after the first month as patients complete dose escalation. Mysimba carries specific contraindications including uncontrolled hypertension, seizure disorders, eating disorders, and concurrent use of opioid medications. Blood pressure monitoring is required during treatment.

Semaglutide-based treatments predominantly cause gastrointestinal side effects, with nausea being most common (affecting 20-44% of patients), alongside vomiting, diarrhoea, and constipation [2]. These effects usually improve over time, particularly with gradual dose escalation. Rare but serious risks include pancreatitis, gallbladder disease, and potential thyroid effects. The injectable administration route may concern some patients, though modern pen devices make self-injection straightforward.

Tolerability profiles differ significantly between these treatments. Mysimba's neurological side effects may prove challenging for patients sensitive to stimulant-like effects, whilst semaglutide's gastrointestinal effects can be managed through dietary adjustments and slower dose titration. Your UK prescriber will assess which side effect profile aligns better with your medical history and lifestyle.

Feature Mysimba Ozempic/Wegovy
Active Ingredient Naltrexone 8mg + Bupropion 90mg Semaglutide
Administration Oral tablet, twice daily Subcutaneous injection, once weekly
Mechanism Neurological appetite modulation GLP-1 receptor agonist
Average Weight Loss 5-6% over 56 weeks 14.9% over 68 weeks
Common Side Effects Nausea, headache, insomnia Nausea, vomiting, diarrhoea
Starting Price From £125.95 From £89.00

Suitability and Contraindications: Who Can Use Each Treatment

Mysimba is typically prescribed for adults with BMI ≥30 kg/m² or BMI ≥27 kg/m² with weight-related comorbidities, subject to prescriber assessment [3]. Absolute contraindications include uncontrolled hypertension, seizure history, eating disorders, bipolar disorder, hepatic impairment, and current opioid use. Patients taking certain antidepressants or with cardiovascular disease require careful evaluation. The oral route suits those uncomfortable with injections or preferring tablet-based treatment.

Semaglutide-based treatments share similar BMI criteria but have different contraindication profiles. Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 represent absolute contraindications [2]. Patients with diabetic retinopathy, renal impairment, or history of pancreatitis require specialist assessment. The injectable format provides consistent absorption and eliminates concerns about gastrointestinal medication absorption issues.

Pregnancy and breastfeeding contraindicate both treatments. Women of childbearing potential require reliable contraception during treatment and for specified periods after discontinuation. Your clinical assessment at Cured Pharmacy includes comprehensive review of medical history, current medications, and individual risk factors to determine appropriate treatment selection.

Special Considerations for UK Patients

Patients with type 2 diabetes may find semaglutide-based options particularly suitable given the additional glycaemic benefits, though this requires coordination with existing diabetes management. Those with hypertension concerns might prefer semaglutide over Mysimba, which requires blood pressure monitoring. Our superintendent pharmacist Tarun Kumar ensures all clinical decisions align with current MHRA guidance and NICE recommendations for weight management interventions.

Administration and Treatment Schedules: Practical Considerations

Mysimba requires daily oral administration following a specific escalation schedule. Patients begin with one tablet daily in week one, increasing to one tablet twice daily in week two, then two tablets in the morning and one in the evening during week three, reaching the maintenance dose of two tablets twice daily by week four [1]. This gradual increase helps minimise side effects. Treatment continues long-term, with response assessment at 16 weeks.

Semaglutide-based injections follow a weekly schedule using pre-filled pen devices. Treatment begins at lower doses with monthly increases over 16-20 weeks until reaching the maintenance dose, allowing gradual tolerance development [2]. The once-weekly administration offers convenience compared to daily tablets, though it requires proper injection technique and refrigerated storage before first use.

Adherence patterns differ between daily oral and weekly injectable formats. Some patients prefer the routine of daily tablets, whilst others value the convenience of weekly injections. Missing doses affects efficacy differently: missed Mysimba tablets should be skipped if near the next scheduled dose, whilst delayed semaglutide injections can be administered within five days of the scheduled day. Your prescriber will provide detailed administration guidance specific to your chosen treatment.

Making Your Decision: Mysimba vs Ozempic UK Treatment Selection

Treatment selection depends on multiple individual factors rather than a universal 'best' option. Consider Mysimba if you prefer oral medication, cannot use injectable treatments due to needle phobia or practical constraints, or have contraindications to GLP-1 therapies. The neurological mechanism may suit patients who identify strong psychological components to their eating patterns, subject to appropriate psychiatric screening.

Semaglutide-based options may be preferable if you seek higher average weight loss outcomes demonstrated in clinical trials, have type 2 diabetes requiring glycaemic management, or prefer weekly administration over daily tablets. The injectable format suits patients comfortable with self-administration and requiring medication that bypasses gastrointestinal absorption variability.

At Cured Pharmacy, our free online consultation takes under three minutes and allows UK prescribers to assess your complete medical picture. We offer transparent upfront pricing and stock genuine UK-licensed medications only. Whether you proceed with Mysimba from £135.00 or explore alternative options like Wegovy or Mounjaro, our clinical team ensures you receive appropriate treatment matching your individual circumstances, medical history, and weight management goals.

Next Steps: Starting Your Weight Loss Journey

Begin with our confidential online assessment, completed entirely through our secure platform. Our UK-registered prescribers review your submission, considering your BMI, medical history, current medications, and previous weight loss attempts. If treatment is deemed suitable and safe, we dispense your medication in discreet packaging with comprehensive instructions. Ongoing support ensures you understand administration, recognise side effects requiring medical attention, and optimise your treatment outcomes through evidence-based lifestyle modifications.

Scientific References

  1. Greenway, F. L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595-605. https://doi.org/10.1016/S0140-6736(10)60888-4 [accessed 13 August 2026]
  2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  3. National Institute for Health and Care Excellence. (2014). Weight management: lifestyle services for overweight or obese adults (PH53). NICE guideline. https://www.nice.org.uk/guidance/ph53 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to lifestyle modifications alongside pharmacological treatment.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Mysimba or Ozempic better for weight loss in the UK?
Clinical trials show semaglutide (Ozempic/Wegovy) achieves higher average weight loss than Mysimba, but individual suitability depends on your medical history, contraindications, and preferences regarding oral versus injectable administration. A UK prescriber assessment determines which option is safest and most appropriate for you.
Can I switch from Mysimba to Ozempic or vice versa?
Yes, switching between treatments is possible under prescriber supervision, though you cannot take both simultaneously. Your UK prescriber will assess whether switching is appropriate based on your response to initial treatment, side effects experienced, and ongoing clinical suitability.
Which has fewer side effects, Mysimba or Ozempic?
Both treatments cause side effects in most patients initially, but the types differ: Mysimba predominantly causes neurological effects like headache and insomnia, whilst semaglutide mainly causes gastrointestinal symptoms. Neither is universally better tolerated; individual response varies considerably.
How long does it take to see results with Mysimba vs Ozempic?
Mysimba typically shows measurable weight loss within 16 weeks, with assessment at this point determining continuation. Semaglutide often produces noticeable appetite reduction within days, with progressive weight loss over months as doses increase to maintenance levels.
Do I need a prescription for Mysimba or Ozempic in the UK?
Yes, both are prescription-only medications requiring clinical assessment by a UK-registered prescriber. At Cured Pharmacy, this assessment is completed through our free online consultation, with prescriptions issued only when clinically appropriate and safe.
Can I take Mysimba and Ozempic together for faster weight loss?
No, combining these treatments is not recommended or licensed in the UK. Using multiple weight loss medications simultaneously increases risks without established safety or efficacy data. Your prescriber will recommend a single appropriate option based on your individual assessment.
Which is cheaper, Mysimba or Ozempic, at UK pharmacies?
At Cured Pharmacy, Mysimba starts from £135.00, whilst Wegovy (the weight-loss licensed semaglutide product) starts from £135.00. However, treatment selection should prioritise clinical suitability and expected outcomes rather than cost alone, as effectiveness varies between individuals.
Will my weight loss continue long-term with Mysimba vs Ozempic?
Both treatments support weight loss primarily whilst actively used, with weight regain common after discontinuation unless lifestyle changes are maintained. Clinical trials show continued benefit during ongoing treatment, but long-term success requires sustained dietary and activity modifications alongside pharmacological support.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.